Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vertex Pharmaceuticals

492.47
+0.05000.01%
Post-market: 492.470.00000.00%16:34 EDT
Volume:1.37M
Turnover:672.88M
Market Cap:126.60B
PE:-236.76
High:494.10
Open:492.42
Low:486.65
Close:492.42
Loading ...

Amdocs and Google Cloud Announce Partnership Expansion to Optimize 5G Network Operations with AI

PR Newswire
·
27 Feb

Vertex announces enhancement of Vertex e-Invoicing

TIPRANKS
·
26 Feb

Vertex Expands e-Invoicing Capabilities to Streamline Compliance & Reporting

GlobeNewswire
·
26 Feb

Vertex Pharmaceuticals upgraded to Buy from Hold at Erste Group

TIPRANKS
·
26 Feb

Vertex Minerals Director Increases Stake with Share Acquisition

TIPRANKS
·
25 Feb

Vertex's FDA Win: A Billion-Dollar Bet on Safer Pain Treatment

GuruFocus.com
·
25 Feb

RBC says Journavx review documents hint at focus in future chronic pain data

TIPRANKS
·
25 Feb

Vertex to Report Q4 Earnings: What's in Store for the Stock?

Zacks
·
24 Feb

Countdown to Vertex (VERX) Q4 Earnings: Wall Street Forecasts for Key Metrics

Zacks
·
24 Feb

High Growth Tech Stocks To Watch In February 2025

Simply Wall St.
·
24 Feb

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Telix Pharmaceuticals Ltd. (OtherTLPPF), Repligen (RGEN) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
24 Feb

Cautious Hold on Vertex Pharmaceuticals Amid Early-Stage Uncertainty of VX-522 Development

TIPRANKS
·
24 Feb

Vertex Pharmaceuticals Incorporated (VRTX): Among Renaissance Technologies Portfolio’s Top Stock Picks

Insider Monkey
·
24 Feb

3 Magnificent Growth Stocks to Buy Right Now

Motley Fool
·
22 Feb

2 No-Brainer Healthcare Stocks to Buy With $500 Right Now

Motley Fool
·
21 Feb

Vertex Pharmaceuticals Inc : RBC Raises Target Price to $408 From $407

THOMSON REUTERS
·
20 Feb

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
20 Feb

CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?

Zacks
·
18 Feb

3 Stocks That Could Trounce the Market in 2025

Motley Fool
·
17 Feb

2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025

Motley Fool
·
15 Feb